Purchase of new ChemiDoc™ MP Imaging system from BioRad
Closed Pre-Solicitation Posted
- Solicitation number
- 75N98026Q00856BIORAD
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of Logistics and Acquisition Operations, intends to procure a ChemiDoc™ MP Imaging system from BioRad Laboratories, Inc. under simplified acquisition procedures without full and open competition, with responses due July 31, 2026, at 9:00 AM Eastern time. The award is anticipated not to exceed the simplified acquisition threshold of $350,000.
The instrument will support lung cancer research conducted by the Thoracic and Surgical Branch. Researchers will use the system to visualize and evaluate protein expression in vitro and in vivo, enabling basic and translational research on thoracic malignancies, molecular profiling, and biomarker discovery and validation. Work is performed at NIH facilities supporting the Office of the Director.
The Government reserves the right to decide whether to proceed on a non-competitive basis or conduct a competitive procurement based on responses received. Offerors must submit technical proposals, cost-price proposals, period of performance, Unique Entity ID, Taxpayer Identification Number, and business size certification. All offerors must maintain active SAM registration. The procurement is classified under NAICS 325414 (Biological Product Manufacturing, except Diagnostic) with a $34 million size standard, and PSC 6640 (Laboratory Equipment and Supplies). Submit responses electronically to Mr. Vishnuvajjala Hanumanth Rao, Lead Purchasing Agent, at vishnuh@mail.nih.gov.
Notice text
LABS IN TSP BRANCH HAVE THE PRIMARY RESEARCH INTREST ON THE CAUSE OF LUNG CANCER IS THE LEADING CAUSE OF CANCER-RELATED DEATHS WORLDWIDE. vISUALIZING PROTEIN EXPRESSION AND EVALUATING THE LEVEL OF PROTEIN EXPRESSION IN THE VITRO AND IN VIVO IS A POWERFUL APPROACH FOR CANCER RESEARCH. THE PURCHASE OF THIS CHEMIDIC tm MP IMAGING SYSTEM INSTRUMENT WILL ALLOW RESEARCHERS IN TSB TO UNDERSTAND BASIC AND TRANSLATIONAL RESEARCH PERTAINING TO THORACIC MALIGNANCIES MOLECULAR PROFILING, BIOMARKER DISCOVERY. VIOLATION AND TO ADVANCE OUR RESEARCH PACE.
Files
| File | Type | Posted |
|---|---|---|
| NOTICE OF INTENT BIO RAD -PCA NCI 08465.docx | DOCX document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity